Literature DB >> 19582468

[Fibromyalgia--the new guideline].

W Brückle1.   

Abstract

To date, the long-term course of fibromyalgia (FM) generally shows little improvement and many patients have problems managing their private, social and professional lives, if at all. Health workers in various specialties, and even in the same specialty, have differing concepts on etiology, diagnosis and treatment of FM. In its work spanning 2 years, an interdisciplinary working group made up from 10 scientific associations reviewed the literature and developed an S3-level consensus guideline. Various etiopathogenetic concepts converge from the perspective of a biopsychosocial model. A stepwise treatment approach with patient education, endurance training, multi-modal therapy and promotion of significant resources is recommended. Of the psychotherapeutic methods, cognitive behavioural training has proved the most relevant. Only a handful of drug therapies have undergone controlled trials, most however only over a period of a few weeks.

Entities:  

Mesh:

Year:  2009        PMID: 19582468     DOI: 10.1007/s00393-009-0454-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  21 in total

1.  [Pharmacological treatment of fibromyalgia syndrome].

Authors:  C Sommer; W Häuser; M Berliner; W Brückle; S Ehlers; K Mönkemöller; B Moradi; F Petzke; N Uçeyler; R Wörz; E Winter; D O Nutzinger
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

2.  [Fibromyalgia syndrome: guideline principle for a fiction?].

Authors:  W Häuser
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

3.  [Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain].

Authors:  C Sommer; W Häuser; K Gerhold; P Joraschky; F Petzke; T Tölle; N Uçeyler; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

4.  [Methodological fundamentals for the development of the guideline].

Authors:  K Bernardy; P Klose; N Uçeyler; I Kopp; W Häuser
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

5.  [Juvenile fibromyalgia syndrome].

Authors:  H Michels; K Gerhold; R Häfner; W Häuser; A Illhardt; K Mönkemöller; M Richter; L Schuchmann
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

6.  Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia.

Authors:  Richard H Gracely; Frank Petzke; Julie M Wolf; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2002-05

7.  [Multicomponent therapy for treatment of fibromyalgia syndrome].

Authors:  B Arnold; W Häuser; K Bernardy; W Brückle; E Friedel; V Köllner; H Kühn-Becker; M Richter; M Weigl; T Weiss; M Offenbächer
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

8.  Responder criteria for operant and cognitive-behavioral treatment of fibromyalgia syndrome.

Authors:  Kati Thieme; Dennis C Turk; Herta Flor
Journal:  Arthritis Rheum       Date:  2007-06-15

Review 9.  EULAR evidence-based recommendations for the management of fibromyalgia syndrome.

Authors:  S F Carville; L Arendt-Nielsen; S Arendt-Nielsen; H Bliddal; F Blotman; J C Branco; D Buskila; J A P Da Silva; B Danneskiold-Samsøe; F Dincer; C Henriksson; K G Henriksson; E Kosek; K Longley; G M McCarthy; S Perrot; M Puszczewicz; P Sarzi-Puttini; A Silman; M Späth; E H Choy
Journal:  Ann Rheum Dis       Date:  2007-07-20       Impact factor: 19.103

10.  Idiopathic musculoskeletal pain syndromes in children.

Authors:  P N Malleson; M al-Matar; R E Petty
Journal:  J Rheumatol       Date:  1992-11       Impact factor: 4.666

View more
  3 in total

1.  [Fibromyalgia syndrome guideline: Interim assessment].

Authors:  M Settan; S Eis; W Häuser
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

2.  [Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].

Authors:  U Marschall; B Arnold; W Häuser
Journal:  Schmerz       Date:  2011-08       Impact factor: 1.107

3.  Patients' and professionals' views on managing fibromyalgia.

Authors:  Erica Briones-Vozmediano; Carmen Vives-Cases; Elena Ronda-Pérez; Diana Gil-González
Journal:  Pain Res Manag       Date:  2013 Jan-Feb       Impact factor: 3.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.